Dear All,
in a recent newsletter BCN health outlined that the Spanish Ministry is getting increasingly wary of too high prices on cancer drugs. They have stated that if the products fail to demonstrate cost-effectiveness they will not be funded by the NHS. Various drugs are stuck in the Spanish Ministries' pricing commission.
Indeed I also saw a lot of articles recently on the new pricing system to be implemented. Some lawyers talk about the need of an "entire new house" for the system of drug price setting in Spain. Clearly the involvement of more economic analysis in terms of cost effectiveness and budget impact will be part of it. I believe reference pricing will also play an import role coupled with more risk sharing that we see emerging in certain communities. The bigger pricing threads comes from those who like to introduce more centralized tender purchasing.
There are no signs of recovery of the Spanish economy hence serious pricing pressures will continue throughout 2013 and beyond.
Cheers
Ulf
2.08.2013
Recordings eyeforpharma AMNOG webinar
Dear All,
just got the word from eyeforpharma that the webinar on how to overcome the AMNOG hurdles to achieve access in Germany’s market was a great success last week. They’ve just finished putting together the recordings for you.
Over 400 people listened to the payer panel as Dr. Mathias Flume, Physicians Association, Westphalia-Lippe, Dr Detlev Parow, Statutory Health Insurance, DAK Deutsche Angestellten Krankenkasse and Andreas Guhl, Founder, ValueMAxes shared exclusive insights with the audience.
You can check out the recordings here
Cheers
Ulf
just got the word from eyeforpharma that the webinar on how to overcome the AMNOG hurdles to achieve access in Germany’s market was a great success last week. They’ve just finished putting together the recordings for you.
Over 400 people listened to the payer panel as Dr. Mathias Flume, Physicians Association, Westphalia-Lippe, Dr Detlev Parow, Statutory Health Insurance, DAK Deutsche Angestellten Krankenkasse and Andreas Guhl, Founder, ValueMAxes shared exclusive insights with the audience.
You can check out the recordings here
Cheers
Ulf
2.01.2013
HEOR Consultant Basel, Switzerland
Dear All,
this is a current search, please contact Theo (below) if interested.
Cheers
Ulf
As the Health Economics and Outcomes Research market continues to grow, this global consultancy is seeking an organised and experienced individual to lead teams and work within a stimulating environment as a HEOR Consultant. Based in Switzerland, you will possess a profound knowledge of HEOR and will have experience of working within the pharma and healthcare industry.
Being part of a fast-growing and highly successful division, you will focus upon delivering tangible business results to clients and business managers across the international pharmaceutical and healthcare industries. You will also be heavily involved in outcomes research, economic analysis and the natural history of a disease, HEOR consultants will work with a diverse mix of clients, typically including the global top 20 pharmaceutical companies.
Responsibilities:
- Reviews and analyses client requirements in order to help develop proposals for cost-effective solutions
- Organises and conducts high quality research for clients with input and review by colleagues
- Has a thorough knowledge of consulting methodologies and the health care sector
- Contributes to the development of value dossiers and support material for clients
- Engagement based responsibilities are assigned and managed by senior consultants, engagement managers or principals
- Performs outcomes research, health economic analyses or environment analyses to assist in the identification of client issues and the development of client specific solutions
- Supports systematic review and meta analysis projects
Qualifications:
- BA/BSc in science or economics or related discipline essential
- MSc/MPhil/PhD in economics/health economics health services research or a relevant related area
Experience:
- Post-graduate work experience in a related area (such as economics, health economics, statistics, psychology or science)
- Experience in undertaking economic analysis (in either Pharmaceutical or other Healthcare Industry, Academic Organisation, HTA Group, or Health Services Research).
Successful candidates will be fluent in English and possess strong business/scientific written. Having strong written and verbal communication skills, they will have the ability to build strong consultative business relationships. Being able to deliver high quality work with strong attention to detail is crucial. An established net work of referrals and contacts is advantageous
Being part of a fast-growing and highly successful division, you will focus upon delivering tangible business results to clients and business managers across the international pharmaceutical and healthcare industries. You will also be heavily involved in outcomes research, economic analysis and the natural history of a disease, HEOR consultants will work with a diverse mix of clients, typically including the global top 20 pharmaceutical companies.
Responsibilities:
- Reviews and analyses client requirements in order to help develop proposals for cost-effective solutions
- Organises and conducts high quality research for clients with input and review by colleagues
- Has a thorough knowledge of consulting methodologies and the health care sector
- Contributes to the development of value dossiers and support material for clients
- Engagement based responsibilities are assigned and managed by senior consultants, engagement managers or principals
- Performs outcomes research, health economic analyses or environment analyses to assist in the identification of client issues and the development of client specific solutions
- Supports systematic review and meta analysis projects
Qualifications:
- BA/BSc in science or economics or related discipline essential
- MSc/MPhil/PhD in economics/health economics health services research or a relevant related area
Experience:
- Post-graduate work experience in a related area (such as economics, health economics, statistics, psychology or science)
- Experience in undertaking economic analysis (in either Pharmaceutical or other Healthcare Industry, Academic Organisation, HTA Group, or Health Services Research).
Successful candidates will be fluent in English and possess strong business/scientific written. Having strong written and verbal communication skills, they will have the ability to build strong consultative business relationships. Being able to deliver high quality work with strong attention to detail is crucial. An established net work of referrals and contacts is advantageous
To apply, or for further information, please contact Theo Rowley on +44 (0) 207 440 0679 / t.rowley@proclinical.co.uk. Alternatively, contact him via LinkedIn.
Subscribe to:
Posts (Atom)
Blog Archive
-
►
2008
(75)
- January (14)
- February (7)
- March (10)
- April (6)
- May (4)
- June (3)
- July (7)
- August (3)
- September (4)
- October (9)
- November (5)
- December (3)
-
►
2009
(41)
- January (8)
- February (4)
- March (4)
- April (4)
- May (1)
- June (5)
- July (2)
- August (3)
- September (3)
- October (2)
- November (2)
- December (3)
-
►
2010
(31)
- January (1)
- February (8)
- March (2)
- May (2)
- June (2)
- July (3)
- August (2)
- September (4)
- October (3)
- November (2)
- December (2)
-
►
2011
(29)
- January (6)
- February (3)
- March (1)
- May (2)
- June (4)
- July (3)
- August (2)
- September (4)
- October (3)
- November (1)
-
►
2012
(16)
- January (1)
- February (4)
- May (3)
- July (2)
- August (1)
- October (1)
- November (1)
- December (3)